Sponsor content
6 result(s) found, displaying 1 to 6
-
Australian public assessment report (AusPar)Vyvgart is indicated as an add on to standard therapy for the treatment of adult patients with generalised Myasthenia Gravis (gMG) who are anti acetylcholine receptor (AChR) antibody positive.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VYVGART efgartigimod alfa 1000 mg/5 mL solution for injection prefilled syringe.
-
Sep-2025Prescription medicine evaluationActive ingredient: efgartigimod alfa.
-
VYVGART efgartigimod alfa 400 mg/20 mL concentrated injection for intravenous infusion vial (444955)
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VYVGART efgartigimod alfa 400 mg/20 mL concentrated injection for intravenous infusion vial. -
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VYVGART efgartigimod alfa 1000 mg/5.6 mL solution for injection vial.
-
Prescription medicine registrationActive ingredients: efgartigimod alfa.